Hamilton Lane Launches Global Private Secondary Fund
Get Alerts HLNE Hot Sheet
Join SI Premium – FREE
- The global evergreen fund for secondaries investment seeks to offer a diversified portfolio of mature private equity investments positioned for value creation by leveraging the firm's 24+ years of experience in the secondary market and extensive scale
- This launch marks the 10th fund in Hamilton Lane's
$12 billion+ AUM evergreen platform
HLGPS seeks to provide investors with long-term capital appreciation primarily by building a diversified portfolio of secondary investments. The Fund offers access to high-quality private market investments diversified across strategies, industries, vintages and geography, in a single fund with quarterly limited liquidity. The Fund's strategy focuses on high quality middle market buyout funds and assets, with significant near-term distribution potential. It is also able to employ a flexible approach across secondary transaction types by leveraging Hamilton Lane's 24+ year experience in the secondary market and substantial capital deployment.
In comparison to primary investments, secondary investments can typically present benefits such as diversification, J-curve mitigation, knowledge of underlying assets, increased pace of capital deployment and value through discounts.
HLGPS is the latest addition to Hamilton Lane's broader
About Hamilton Lane
Hamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout
1As of
2 As of
View original content:https://www.prnewswire.com/news-releases/hamilton-lane-launches-global-private-secondary-fund-302544369.html
SOURCE Hamilton Lane
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026
- Cardano Price Prediction: Leios Targets 3 to 5 Times Initial Capacity as Remittix Plans a 64.3% Final Presale Price Step
- Family Research Council President Tony Perkins to Speak at Missouri and Kansas Churches This Sunday
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share